Dr Freya Bruveris
Dr Freya Bruveris
Dr Freya Bruveris is the Project Manager of the Blood Development and Immune Development Laboratories at the Murdoch Children's Research Institute (MCRI). These laboratories are part of the Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Melbourne Node, a global consortium working to transform people’s lives through stem cell medicine. In her role as Project Manager, her interests lie in successful research program management, developing commercialisation options, fostering relationships with industry and biotech companies, outreach to patient and consumer groups and GMP translation of stem-cell-based cellular therapies.
After completing her PhD in Haematology at Monash University, Dr Bruveris took a postdoctoral research position training under Prof Andrew Elefanty and Prof Ed Stanley at the Murdoch Children's Research Institute in Melbourne, Australia. As a Stem Cell Biologist, she gained extensive knowledge of haematopoietic and endothelial differentiation, training in developmental haematopoiesis and vascular development and in vitro culture and manipulation of human pluripotent stem cells.
After completing her PhD in Haematology at Monash University, Dr Bruveris took a postdoctoral research position training under Prof Andrew Elefanty and Prof Ed Stanley at the Murdoch Children's Research Institute in Melbourne, Australia. As a Stem Cell Biologist, she gained extensive knowledge of haematopoietic and endothelial differentiation, training in developmental haematopoiesis and vascular development and in vitro culture and manipulation of human pluripotent stem cells.
Dr Freya Bruveris is the Project Manager of the Blood Development and Immune Development Laboratories at the Murdoch Children's Research Institute (MCRI). These laboratories are part of the Novo Nordisk Foundation Centre for Stem Cell Medicine...
Dr Freya Bruveris is the Project Manager of the Blood Development and Immune Development Laboratories at the Murdoch Children's Research Institute (MCRI). These laboratories are part of the Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Melbourne Node, a global consortium working to transform people’s lives through stem cell medicine. In her role as Project Manager, her interests lie in successful research program management, developing commercialisation options, fostering relationships with industry and biotech companies, outreach to patient and consumer groups and GMP translation of stem-cell-based cellular therapies.
After completing her PhD in Haematology at Monash University, Dr Bruveris took a postdoctoral research position training under Prof Andrew Elefanty and Prof Ed Stanley at the Murdoch Children's Research Institute in Melbourne, Australia. As a Stem Cell Biologist, she gained extensive knowledge of haematopoietic and endothelial differentiation, training in developmental haematopoiesis and vascular development and in vitro culture and manipulation of human pluripotent stem cells.
After completing her PhD in Haematology at Monash University, Dr Bruveris took a postdoctoral research position training under Prof Andrew Elefanty and Prof Ed Stanley at the Murdoch Children's Research Institute in Melbourne, Australia. As a Stem Cell Biologist, she gained extensive knowledge of haematopoietic and endothelial differentiation, training in developmental haematopoiesis and vascular development and in vitro culture and manipulation of human pluripotent stem cells.
Top Publications
- Bruveris, FF, Ng, ES, Stanley, EG, Elefanty, AG. VEGF, FGF2, and BMP4 regulate transitions of mesoderm to endothelium and blood cells in a human model of yolk sac hematopoiesis.. Exp Hematol 103: 30 -39.e2 2021 view publication
- Bruveris, FF, Ng, ES, Leitoguinho, AR, Motazedian, A, Vlahos, K, Sourris, K, Mayberry, R, McDonald, P, Azzola, L, Davidson, NM, et al. Human yolk sac-like haematopoiesis generates RUNX1-, GFI1- and/or GFI1B-dependent blood and SOX17-positive endothelium.. Development 147(20) : 2020 view publication
- Motazedian, A, Bruveris, FF, Kumar, SV, Schiesser, JV, Chen, T, Ng, ES, Chidgey, AP, Wells, CA, Elefanty, AG, Stanley, EG. Multipotent RAG1+ progenitors emerge directly from haemogenic endothelium in human pluripotent stem cell-derived haematopoietic organoids.. Nat Cell Biol 22(1) : 60 -73 2020 view publication
- Bruveris, FF, Ng, ES, Leitoguinho, AR, Motazedian, A, Vlahos, K, Sourris, K, Mayberry, R, McDonald, P, Azzola, L, Davidson, NM, et al. Human yolk sac-like haematopoiesis generates RUNX1- and GFI1/1B-dependent blood and SOX17-positive endothelium.. Development 2020 view publication
- Vlahos, K, Sourris, K, Mayberry, R, McDonald, P, Bruveris, FF, Schiesser, JV, Bozaoglu, K, Lockhart, PJ, Stanley, EG, Elefanty, AG. Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults.. Stem Cell Res 34: 101380 2019 view publication
Page 1 of 4
Career information
Share //
